Roche Holding AG
SIX:ROG
Roche Holding AG
Cash from Financing Activities
Roche Holding AG
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Cash from Financing Activities
-CHf4.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
Novartis AG
SIX:NOVN
|
Cash from Financing Activities
-$10.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Financing Activities
$17.4m
|
CAGR 3-Years
249%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Financing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Cash from Financing Activities?
Cash from Financing Activities
-4.2B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Cash from Financing Activities amounts to -4.2B CHF.
What is Roche Holding AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
12%
Over the last year, the Cash from Financing Activities growth was 74%. The average annual Cash from Financing Activities growth rates for Roche Holding AG have been 24% over the past three years , 17% over the past five years , and 12% over the past ten years .